Patent ID: 7560442

Claim:
A method for treating diabetes mellitus Type I and Type II, polyneuropathy, heavy metal poisoning, cerebral ischemic disease, depression, and stroke, in a mammal, which comprises administering to said mammal an amount of a drug combination comprising: at least one fatty acid selected from the group consisting of linoleic acid, γ-linolenic acid, dihomo-γ-linolenic acid, α-linolenic acid, (R,S)-lipoic acid, (S)-lipoic acid, (R)-lipoic acid, linoleic acid C1-C7 alkyl ester, γ-linolenic acid C1-C7 alkyl ester, dihomo-γ-linolenic acid C1-C7 alkyl ester, α-linolenic acid C1-C7 alkyl ester, (R,S)-lipoic acid C1-C7 alkyl ester, (S)-lipoic acid C1-C7 alkyl ester, (R)-lipoic acid C1-C7 alkyl ester, (R,S)-6,8-dithiane octanoic acid C1-C7 alkyl ester, (R)-6,8-dithiane octanoic acid C1-C7 alkyl ester and (S)-6,8-dithiane octanoic acid C1-C7 alkyl ester, together with at least one nucleoside and/or nucleotide compound of uridine, deoxyuridine, uridine monophosphate, deoxyuridine monophosphate, or pharmaceutically acceptable salts of said combination, effective to treat the disease and/or effective to stimulate the organism of said mammal.